Trial intelligence / Profile preview

Impact of tamsulosin on pupil size after tropicamide and phenylephrine

2015-003064-36Phase 4Completed

Sponsor
Vienna Institute for Research in Ocular Surgery
Start
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of tamsulosin in intraoperative floppy iris syndrome (IFIS), cataract and None (2 arms), sponsored by Vienna Institute for Research in Ocular Surgery. Primary endpoint: Change in pupil size after mydriatic drops. Started Jul 2015; status: completed.

02

Drugs

tamsulosin
03

Conditions

intraoperative floppy iris syndrome (IFIS)cataract

Beyond the preview

Go deeper on 2015-003064-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-003064-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call